Valsts: Izraēla
Valoda: ivrits
Klimata pārmaiņas: Ministry of Health
PALIFERMIN 6.25 MG/VIAL
MEGAPHARM LTD
V03AF08
SOLUTION FOR INJECTION
I.V
SWEDISH ORPHAN BIOVITRUM, SWEDEN
PALIFERMIN
Kepivance is indicated to decrease the incidence, duration and severity of oral mucositis in patients with haematological malignancies receiving myeloablative therapy associated with a high incidence of severe mucositis and requiring autologous haemopoietic stem cell support.
2011-08-01